Topping tamoxifen as 1st-line Rx for postmenopausal breast Ca

Aromatase inhibitors should replace tamoxifen as the first choice for preventing recurrence of breast cancer in postmenopausal women with localized hormone receptor-positive disease, according to this large-scale study.

Related Videos
Lewkowitz, Peahl, Shah
Haywood Brown, MD | Image credit: © USF Health
Anne Banfield, MD | Image Credit: © Medstar
Gloria Richard-Davis MD, MBA, NCMP, FACOG
© 2023 MJH Life Sciences

All rights reserved.